Sanofi Consumer Healthcare India (NSE:SANOFICONR) Institutional Ownership: 17.04% (As of Aug. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SANOFICONR Sanofi Consumer Healthcare India Ltd NSE:SANOFICONR
22 GF Score
Price ₹4,222.10
! 2 Warning Signs
View Full Analysis

What is Sanofi Consumer Healthcare India Institutional Ownership?

Sanofi Consumer Healthcare India NSE:SANOFICONR +0.21% 22 Institutional Ownership is 17.04% as of Aug. 22, 2026. GuruFocus rates NSE:SANOFICONR with a GF Score™ of 22/100. The stock has 2 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Sanofi Consumer Healthcare India's institutional ownership is 17.04%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Sanofi Consumer Healthcare India's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Sanofi Consumer Healthcare India's Float Percentage Of Total Shares Outstanding is 0.00%.

Sanofi Consumer Healthcare India Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Sanofi Consumer Healthcare India's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sanofi Consumer Healthcare India Institutional Ownership Chart

Sanofi Consumer Healthcare India Historical Data

The historical data trend for Sanofi Consumer Healthcare India can be seen below:

2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31
Institutional Ownership 17.37 17.40 17.47 17.60 17.74 17.75 17.87 17.92 17.21 17.04
NSE:SANOFICONR
22GF Score
Sanofi Consumer Healthcare India Ltd NSE:SANOFICONR
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sanofi Consumer Healthcare India Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 17.04% mean?
Sanofi Consumer Healthcare India (NSE:SANOFICONR) has a Institutional Ownership of 17.04% as of Aug. 22, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Sanofi Consumer Healthcare India and its competitors.
Is Sanofi Consumer Healthcare India's Institutional Ownership too high?
Sanofi Consumer Healthcare India's current Institutional Ownership is 17.04%. Overall, Sanofi Consumer Healthcare India has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Sanofi Consumer Healthcare India's Institutional Ownership compare to LLY and JNJ?
Sanofi Consumer Healthcare India's Institutional Ownership of 17.04% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Sanofi Consumer Healthcare India and its competitors. Sanofi Consumer Healthcare India's current Institutional Ownership is 17.04%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sanofi Consumer Healthcare India stock overvalued right now?
Sanofi Consumer Healthcare India (NSE:SANOFICONR) has a current Institutional Ownership of 17.04%. The current Institutional Ownership is 17.04%. Sanofi Consumer Healthcare India's overall GF Score™ is 22/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Sanofi Consumer Healthcare India (NSE:SANOFICONR), the current Institutional Ownership is 17.04% as of Aug. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sanofi Consumer Healthcare India Business Description

Other Exchanges 544250:India
Address Pirojshanagar, Eastern Express Highway, Unit 1104, 11th Floor, Godrej Two, Vikhroli East, Mumbai, MH, IND, 400079
Sanofi Consumer Healthcare India Ltd is mainly engaged in the business of manufacturing and trading of drugs and pharmaceutical products. The Company also has various independent contract/third-party manufacturers based across the country and provides business support services to its group entity in India. Its products include Allergy Relief (Allegra), Pain Care (Combiflam), and Physical Wellness (DePURA). The Company sells its products in India through independent distributors and outside India. Its operations are limited to one segment, namely Pharmaceutical Business. The Company operates in India, which generates the maximum revenue, and Outside India.
22GF Score

Get the complete analysis for NSE:SANOFICONR

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹4,222.10
Price